New diabetes clinical trial: To Assess the Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Published on: October 17, 2024 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: HD-6277 100mg; Drug: HD-6277 50mg; Drug: HD-6277 25mg; Drug: Placebo
Sponsors: Hyundai Pharm
Not yet recruiting
https://ift.tt/lBGNH04